Jerry C. Jones, the Chief Ethics & Legal Officer of LiveRamp Holdings, Inc., has reported a significant stock transaction following the company's recent merger with MMS USA Holdings, Inc. This transaction, filed on November 2, 2026, is noteworthy as it reflects the ongoing changes in corporate ownership and management structures within the data processing industry.
LiveRamp Holdings, Inc. is a company focused on providing data connectivity and integration services. The company, which trades under the symbol RAMP, is incorporated in Delaware and has its headquarters in San Francisco, California. The recent merger with MMS USA Holdings marks a pivotal moment in LiveRamp's business trajectory.
According to the filing, Jones reported multiple transactions involving LiveRamp's common stock. On November 2, 2026, he disposed of 318,804 shares at a price of $38.50 each, resulting in a total transaction value of approximately $12.3 million. Additionally, he reported transactions involving restricted stock units (RSUs) and performance-vesting restricted stock units (PSUs) that vested as part of the merger agreement.
“At the Effective Time, each share of the Issuer's common stock... was converted into the right to receive an amount in cash equal to $38.50 per share,”
the filing stated. This change follows the merger agreement dated May 16, 2026, which saw Merger Sub merge with and into LiveRamp, making it a wholly owned subsidiary of MMS USA Holdings.
The implications of this transaction extend beyond just Jones and LiveRamp. It may affect other stakeholders involved in the merger, including Publicis Groupe S.A., which played a role in the merger agreement. The data processing and preparation sector, represented by LiveRamp, is witnessing significant consolidation, and this merger is a clear indicator of that trend.
As for what comes next, the filing does not specify any upcoming actions or additional filings related to this transaction. However, the changes in stock ownership and the implications of the merger will likely continue to be closely monitored by industry analysts and stakeholders.
Read Next
Hampton Financial Corp Raises Governance Concerns Over Icon Energy
HCA Healthcare Executive Reports Multiple Stock Transactions
LENZ Therapeutics updates beneficial ownership in SEC filing
LOR Inc. Acquires Over 1.4 Million Shares of Rollins Inc.
Brian Magnusson Reports New Stock Transactions at Lindsay Corp
Klein Lawrence Otto Acquires 25,000 Shares in Oruka Therapeutics







